These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19590236)

  • 1. Toll-like receptors and renal disease.
    Robson MG
    Nephron Exp Nephrol; 2009; 113(1):e1-7. PubMed ID: 19590236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor signaling in the ischemic heart.
    Frantz S; Ertl G; Bauersachs J
    Front Biosci; 2008 May; 13():5772-9. PubMed ID: 18508620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of toll-like receptors in liver transplantation.
    Howell J; Gow P; Angus P; Visvanathan K
    Liver Transpl; 2014 Mar; 20(3):270-80. PubMed ID: 24243591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptors: emerging concepts in kidney disease.
    Anders HJ; Schlöndorff D
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):177-83. PubMed ID: 17420659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective roles for toll-like receptors 2, 4, and 9 in systemic inflammation and immune dysfunction following peripheral tissue injury.
    Darwiche SS; Ruan X; Hoffman MK; Zettel KR; Tracy AP; Schroeder LM; Cai C; Hoffman RA; Scott MJ; Pape HC; Billiar TR
    J Trauma Acute Care Surg; 2013 Jun; 74(6):1454-61. PubMed ID: 23694872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.
    Sukkar MB; Xie S; Khorasani NM; Kon OM; Stanbridge R; Issa R; Chung KF
    J Allergy Clin Immunol; 2006 Sep; 118(3):641-8. PubMed ID: 16950283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-Like Receptors Regulate the Development and Progression of Renal Diseases.
    Liu M; Zen K
    Kidney Dis (Basel); 2021 Jan; 7(1):14-23. PubMed ID: 33614730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor signaling in liver ischemia and reperfusion.
    Chang WJ; Toledo-Pereyra LH
    J Invest Surg; 2012 Aug; 25(4):271-7. PubMed ID: 22853814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
    Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
    Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial nucleic acids pay a Toll in kidney disease.
    Pawar RD; Patole PS; Wörnle M; Anders HJ
    Am J Physiol Renal Physiol; 2006 Sep; 291(3):F509-16. PubMed ID: 16597607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.
    Howell J; Sawhney R; Testro A; Skinner N; Gow P; Angus P; Ratnam D; Visvanathan K
    Liver Transpl; 2013 Oct; 19(10):1099-107. PubMed ID: 23894100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking the toll of kidney disease.
    Shirali AC; Goldstein DR
    J Am Soc Nephrol; 2008 Aug; 19(8):1444-50. PubMed ID: 18579638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury.
    Pulskens WP; Teske GJ; Butter LM; Roelofs JJ; van der Poll T; Florquin S; Leemans JC
    PLoS One; 2008; 3(10):e3596. PubMed ID: 18974879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal Toll-like receptors: recent advances and implications for disease.
    El-Achkar TM; Dagher PC
    Nat Clin Pract Nephrol; 2006 Oct; 2(10):568-81. PubMed ID: 17003836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice.
    Patole PS; Pawar RD; Lech M; Zecher D; Schmidt H; Segerer S; Ellwart A; Henger A; Kretzler M; Anders HJ
    Nephrol Dial Transplant; 2006 Nov; 21(11):3062-73. PubMed ID: 16954173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury.
    Farrar CA; Keogh B; McCormack W; O'Shaughnessy A; Parker A; Reilly M; Sacks SH
    FASEB J; 2012 Feb; 26(2):799-807. PubMed ID: 22042224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Toll-like receptors in infection and immunity: clinical implications.
    Cristofaro P; Opal SM
    Drugs; 2006; 66(1):15-29. PubMed ID: 16398566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors and their role in renal pathologies.
    Eleftheriadis T; Pissas G; Liakopoulos V; Stefanidis I; Lawson BR
    Inflamm Allergy Drug Targets; 2012 Dec; 11(6):464-77. PubMed ID: 22931389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors in ischemia-reperfusion injury.
    Arumugam TV; Okun E; Tang SC; Thundyil J; Taylor SM; Woodruff TM
    Shock; 2009 Jul; 32(1):4-16. PubMed ID: 19008778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.